Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists discover gene ’signature’ for tumor’s tendency to spread

09.12.2002


Researchers at Dana-Farber Cancer Institute and the Whitehead Institute have discovered a pattern of genetic activity in several types of primary tumors that appears to predict the likelihood that they will spread, or metastasize, to other parts of the body. If larger studies support these findings, this early indicator of life-threatening cancer spread might lead to a clinical test that would help determine appropriate treatment.



The study will be published by Nature Genetics on its web site on Dec. 9.
Most cancer deaths are caused not by the original or primary tumor but by the metastasizing of tumor cells to other organs. Until now, cancer specialists have viewed the development of metastasis as an essentially random and unpredictable event.

But that notion is thrown into question with the new finding of a genetic "signature" – a certain pattern of activity in a handful of genes – in some solid tumors that appears to preordain them to spreading dangerously. This signature is present in the early stages of the cancer, well before there is any evidence of metastasis, say the researchers.



"These results strongly support the idea that some primary tumors are pre-configured to metastasize, and that this propensity is detectable at the time of initial diagnosis," says Sridhar Ramaswamy, MD, a researcher at Dana-Farber.

Though metastasis is a common and feared event in cancer patients, what triggers it is poorly understood. Cancer cells must undergo a series of changes to become metastatic: they have to acquire the ability to grow while unattached to any tissue, they need to bore through vessel walls to reach the bloodstream or lymphatic system, and they must develop a new blood supply in order to grow. These events are under the control of different genes.

According to the traditional view, a tumor becomes metastatic more or less by chance as a result of a very few maverick cells developing the ability to spread. "It was thought that there was a randomness to it, as new mutations would be constantly arising and some would confer metastatic potential on the tumor," says Ramaswamy.

By contrast, the researchers say their discovery reveals that the tumor is "encoded" with metastatic potential from early on by a certain group of genes, and that this same group is found in a variety of tumor types.

Ramaswamy and his colleagues compared genetic patterns in samples of primary tumors and samples of metastatic cancers. They were seeking genetic differences that might explain why primary cancers stay put while metastatic clumps of cells break off and migrate through the body.

The scientists analyzed the genetic profiles of 64 primary tumors (adenocarcinomas) and 12 samples of cancers that metastasized from other adenocarcinomas. This analysis revealed a set of 128 genes whose expression pattern differed between the primary tumors and the metastases. The scientists were puzzled by instances in which the 128-gene signature associated with the metastatic cancers was also found in some primary tumors. They concluded, though, that the gene expression program of metastasis may already be present in the bulk of some primary tumors at the time of diagnosis.

Further support for this idea came from analysis of samples from 62 lung cancers, which found the metastasis gene signature in many of them. Next, they hypothesized that lung cancer patients whose primary tumors contained the metastatic signature would do more poorly (would survive a shorter time) than those whose tumors lacked the signature. They found that this was the case.

Finally, the scientists looked in the data for a smaller set of genes that could distinguish between primary and metastatic cancer samples. They found a group of 17 genes whose activity pattern could make the distinction, and they tested it in breast cancers, prostate cancers and even in brain tumors called medulloblastomas.

The researchers were surprised to find the same genetic signature associated with metastasis in several different tumor types. "We had no reason to believe it was this broadly applicable,’’ Ramaswamy says, but noted the signature was not evident in lymphoma, a blood cancer that is biologically different from solid tumors.

Further work in larger numbers of tumors is underway as the scientists try to validate the power of the signatures – a necessary step toward a clinical test. Such a test could make a critical difference in treatment of some tumors. For example, up to 30 percent of women with small primary breast cancers have undetectable "micrometastases" that gives them a poorer prognosis. A genetic test that could identify the metastatic potential in those early breast cancers after they’re removed could be of significant benefit in designing treatment.

Previous work with genetic profiles has shown that they can aid classification of hard-to-identify cancers, and can in some cases predict whether a tumor will respond well or poorly to treatment. Together with these discoveries, the new findings "support the emerging notion that the clinical outcome of cancer patients can be predicted using the gene expression profiles of primary tumors at diagnosis," the authors wrote.

Bill Schaller | Nature Genetics
Further information:
http://www.danafarber.org

More articles from Life Sciences:

nachricht Scientists uncover the role of a protein in production & survival of myelin-forming cells
19.07.2018 | Advanced Science Research Center, GC/CUNY

nachricht NYSCF researchers develop novel bioengineering technique for personalized bone grafts
18.07.2018 | New York Stem Cell Foundation

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Future electronic components to be printed like newspapers

A new manufacturing technique uses a process similar to newspaper printing to form smoother and more flexible metals for making ultrafast electronic devices.

The low-cost process, developed by Purdue University researchers, combines tools already used in industry for manufacturing metals on a large scale, but uses...

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

A smart safe rechargeable zinc ion battery based on sol-gel transition electrolytes

20.07.2018 | Power and Electrical Engineering

Reversing cause and effect is no trouble for quantum computers

20.07.2018 | Information Technology

Princeton-UPenn research team finds physics treasure hidden in a wallpaper pattern

20.07.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>